Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP809437.RAQV6f6BRr2oHBRbgTE0_iJbhwycAJKePjJY7hvegnNIE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP809437.RAQV6f6BRr2oHBRbgTE0_iJbhwycAJKePjJY7hvegnNIE130_assertion type Assertion NP809437.RAQV6f6BRr2oHBRbgTE0_iJbhwycAJKePjJY7hvegnNIE130_head.
- NP809437.RAQV6f6BRr2oHBRbgTE0_iJbhwycAJKePjJY7hvegnNIE130_assertion description "[By combined HPV and cytology screening, a further 4% (95% CI: 3-5%) more CIN-3 lesions can be identified but at the expense of a 7% (95% CI: 5-9%) loss in specificity, in comparison with isolated HC2 screening.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP809437.RAQV6f6BRr2oHBRbgTE0_iJbhwycAJKePjJY7hvegnNIE130_provenance.
- NP809437.RAQV6f6BRr2oHBRbgTE0_iJbhwycAJKePjJY7hvegnNIE130_assertion evidence source_evidence_literature NP809437.RAQV6f6BRr2oHBRbgTE0_iJbhwycAJKePjJY7hvegnNIE130_provenance.
- NP809437.RAQV6f6BRr2oHBRbgTE0_iJbhwycAJKePjJY7hvegnNIE130_assertion SIO_000772 16950021 NP809437.RAQV6f6BRr2oHBRbgTE0_iJbhwycAJKePjJY7hvegnNIE130_provenance.
- NP809437.RAQV6f6BRr2oHBRbgTE0_iJbhwycAJKePjJY7hvegnNIE130_assertion wasDerivedFrom befree-20140225 NP809437.RAQV6f6BRr2oHBRbgTE0_iJbhwycAJKePjJY7hvegnNIE130_provenance.
- NP809437.RAQV6f6BRr2oHBRbgTE0_iJbhwycAJKePjJY7hvegnNIE130_assertion wasGeneratedBy ECO_0000203 NP809437.RAQV6f6BRr2oHBRbgTE0_iJbhwycAJKePjJY7hvegnNIE130_provenance.